 MENLO PARK, Calif. and BOSTON, June 28, 2021 GLOBE NEWSWIRE -- Adicet Bio, Inc. Nasdaq: ACET, a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced that the Company has been added to the Russell 2000 Index, effective June 28, 2021, as part of the 2021 Russell indexes annual reconstitution. 